The Competition Commission of India rejected an official complaint lodged against the Health & Family Welfare Department of Odisha, stating the regulator did not find sufficient evidence to open a case. Various parties including medical shop Oracle Drugs issued the complaint against the health department alleging anticompetitive behavior for imposed discounts on healthcare shops at levels higher than initially agreed upon. The department, whose main objective is to provide affordable healthcare, was cleared of any charges as the CCI found the discounts not to be anticompetitive.
Featured News
Jury in Boston Set to Decide Takeda’s Fate in Amitiza Antitrust Trial
May 14, 2026 by
CPI
OnlyFans Faces New Antitrust Lawsuit
May 14, 2026 by
CPI
Americans’ Opposition to Hosting AI Data Centers Hardens, Survey Finds
May 14, 2026 by
CPI
NextEra Energy Agrees to $9.5 Million Settlement in Nuclear Industry Wage-Fixing Case
May 14, 2026 by
CPI
South Korea’s Antitrust Agency Raids Petrochemical Firms in Price-Fixing Probe
May 14, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos